Acute Caffeinated Coffee Consumption Does not Improve Time Trial Performance in an 800-m Run: A Randomized, Double-Blind, Crossover, Placebo-Controlled Study.
Alexandre C MarquesAlison A JesusBruna M GiglioAna C MariniPatrícia C B LoboJoão F MotaGustavo Duarte PimentelPublished in: Nutrients (2018)
CAF consumption failed to enhance the time trial performance of an 800-m run in overnight-fasting runners, when compared with DEC ingestion. In addition, no change was found in RPE, blood pressure levels, or blood glucose and lactate concentrations between the two trials.
Keyphrases
- blood glucose
- double blind
- phase iii
- blood pressure
- placebo controlled
- phase ii
- study protocol
- clinical trial
- open label
- glycemic control
- liver failure
- randomized controlled trial
- heart rate
- respiratory failure
- type diabetes
- insulin resistance
- drug induced
- extracorporeal membrane oxygenation
- skeletal muscle
- mechanical ventilation